Cargando…
Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia
Fibromyalgia (FM) is a complex, multi-symptom condition that predominantly affects women. The majority of those affected are unlikely to gain significant symptomatic control from the few treatments that are approved for FM. In this 10-week, single-blind, crossover trial we tested the immune effects...
Autores principales: | Parkitny, Luke, Younger, Jarred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489802/ https://www.ncbi.nlm.nih.gov/pubmed/28536359 http://dx.doi.org/10.3390/biomedicines5020016 |
Ejemplares similares
-
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
por: Younger, Jarred, et al.
Publicado: (2014) -
Altered response to Toll-like receptor 4 activation in fibromyalgia: A low-dose, human experimental endotoxemia pilot study
por: Jones, Chloe, et al.
Publicado: (2023) -
Effects of Naltrexone on Pain Sensitivity and Mood in Fibromyalgia: No Evidence for Endogenous Opioid Pathophysiology
por: Younger, Jarred W., et al.
Publicado: (2009) -
Evidence for abnormal cytokine expression in Gulf War Illness: A preliminary analysis of daily immune monitoring data
por: Parkitny, Luke, et al.
Publicado: (2015) -
The Effects of Low Dose Naltrexone on Opioid Induced Hyperalgesia and Fibromyalgia
por: Jackson, Daniel, et al.
Publicado: (2021)